| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |